ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04722	Neurotrophin signaling pathway	4/20	160/7206	0.000859149913986
ko05130	Pathogenic Escherichia coli infection	3/20	77/7206	0.00117341185752
ko05131	Shigellosis	3/20	82/7206	0.00140808770737
ko03040	Spliceosome	3/20	145/7206	0.00707780821849
ko05200	Pathways in cancer	5/20	492/7206	0.00955514651397
ko04622	RIG-I-like receptor signaling pathway	2/20	62/7206	0.0125268875025
ko05140	Leishmaniasis	2/20	75/7206	0.0179916240781
ko05169	Epstein-Barr virus infection	3/20	206/7206	0.0183345465322
ko04137	Mitophagy - animal	2/20	82/7206	0.0212838686561
ko05212	Pancreatic cancer	2/20	83/7206	0.0217733886908
ko03018	RNA degradation	2/20	84/7206	0.0222676263664
ko05220	Chronic myeloid leukemia	2/20	85/7206	0.0227665545374
ko04657	IL-17 signaling pathway	2/20	87/7206	0.0237783742812
ko05133	Pertussis	2/20	87/7206	0.0237783742812
ko05222	Small cell lung cancer	2/20	89/7206	0.0248086327667
ko05120	Epithelial cell signaling in Helicobacter pylori infection	2/20	92/7206	0.0263881264257
ko04064	NF-kappa B signaling pathway	2/20	96/7206	0.0285566737488
ko05132	Salmonella infection	2/20	98/7206	0.0296672867837
ko04620	Toll-like receptor signaling pathway	2/20	100/7206	0.0307951836053
ko04014	Ras signaling pathway	3/20	279/7206	0.0401999296289
ko05162	Measles	2/20	120/7206	0.042980436038
ko04660	T cell receptor signaling pathway	2/20	124/7206	0.0456050186367
ko05145	Toxoplasmosis	2/20	126/7206	0.0469395097387
ko05142	Chagas disease (American trypanosomiasis)	2/20	130/7206	0.0496519635469